Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Obese Progestin-insensitive Early-stage Endometrial Cancer Patients With Conservative Treatment

NCT06379113 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.

NCT NCT06379113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06379113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole in Obese Progestin-insensitive Early-stage Endometrial Cancer Patients With Conservative Treatment
Lead sponsor
Xiaojun Chen
Phase
Phase 2/3
Overall status
Recruiting
Start date
July 13, 2022
Completion date
March 30, 2028
Enrollment
29 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, endometrial neoplasms, obesity, progesterone resistance